Octacosanol

Octacosanol

SCHEMBL5935751

CCCCCCCCCCCCCCCCCCCCCCCCCCCCO.O=C(O)c1ccco1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.50
HDAC3 O15379 1/20 0.50
POLB P06746 3/20 0.45
RAB9A P51151 1/20 0.45
DNMT1 P26358 1/20 0.45
ALDH1A1 P00352 5/20 0.45
PKM P14618 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
PTPN1 P18031 1/20 0.44
MAPT P10636 2/20 0.44
LMNA P02545 2/20 0.44
HTT P42858 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
TSHR P16473 3/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ERCC5 P28715 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1,3-Propanediol SCHEMBL28344604 0.86 CES2 (0.54) HDAC3POLBRAB9AALDH1A1PKM
SCHEMBL28495892 0.84 GAA (0.48) GAAHDAC3POLBRAB9ADNMT1
Alcohol SCHEMBL28296602 0.84 CES2 (0.56) GAAHDAC3POLBRAB9AALDH1A1
SCHEMBL27459701 0.84 HDAC3 (0.50) GAAHDAC3POLBRAB9ADNMT1
Ethylene Glycol SCHEMBL28026131 0.82 CES2 (0.58) POLBRAB9AALDH1A1PKMSMN1; SMN2
SCHEMBL28882576 0.81 ALDH1A1 (0.59) POLBRAB9AALDH1A1MEN1KMT2A
SCHEMBL28493498 0.81 HDAC3 (0.50) GAAHDAC3POLBRAB9AALDH1A1
Hydrocinnamyl Alcohol SCHEMBL27945830 0.80 SMN1; SMN2 (0.53) HDAC3RAB9AALDH1A1SMN1; SMN2KMT2A
Butyl Alcohol SCHEMBL27800138 0.79 HDAC3 (0.51) GAAHDAC3POLBALDH1A1PKM
SCHEMBL4418222 0.79 PTGS1 (0.58) GAARAB9AALDH1A1PKMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060020135-A1 Long chain aliphatic alcohol derivatives and methods of making and using same SINO PHARMACEUTICALS CORPORATION (CA) 2006-01-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060020135-A1 Long chain aliphatic alcohol derivatives and methods of making and using same ADH1C, ADH5, NAPRT GAA 2647/4885HDAC3 251/4885POLB 2363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.